Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
- PMID: 20827404
- PMCID: PMC2900561
- DOI: 10.1007/s12072-010-9165-7
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
Abstract
Introduction: The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the management of hepatocellular carcinoma (HCC) in December 2008 to develop consensus recommendations.
Methods: The working party consisted of expert hepatologist, hepatobiliary surgeon, radiologist, and oncologist from Asian-Pacific region, who were requested to make drafts prior to the consensus meeting held at Bali, Indonesia on 4 December 2008. The quality of existing evidence and strength of recommendations were ranked from 1 (highest) to 5 (lowest) and from A (strongest) to D (weakest), respectively, according to the Oxford system of evidence-based approach for developing the consensus statements.
Results: Participants of the consensus meeting assessed the quality of cited studies and assigned grades to the recommendation statements. Finalized recommendations were presented at the fourth APASL single topic conference on viral-related HCC at Bali, Indonesia and approved by the participants of the conference.
Keywords: Consensus statements; Diagnosis; Epidemiology; Hepatocellular carcinoma; Recommendations; Treatment algorithm.
Figures
Similar articles
-
APASL consensus statements and management algorithms for hepatitis C virus infection.Hepatol Int. 2012 Apr;6(2):409-35. doi: 10.1007/s12072-012-9342-y. Epub 2012 Mar 1. Hepatol Int. 2012. PMID: 26201405
-
APASL consensus statements and recommendation on treatment of hepatitis C.Hepatol Int. 2016 Sep;10(5):702-26. doi: 10.1007/s12072-016-9717-6. Epub 2016 Apr 29. Hepatol Int. 2016. PMID: 27130427 Free PMC article. Review.
-
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Hepatol Int. 2016 Sep;10(5):681-701. doi: 10.1007/s12072-016-9736-3. Epub 2016 May 26. Hepatol Int. 2016. PMID: 27229718 Free PMC article. Review.
-
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).Hepatol Int. 2009 Mar;3(1):269-82. doi: 10.1007/s12072-008-9106-x. Epub 2008 Nov 20. Hepatol Int. 2009. PMID: 19669378 Free PMC article.
-
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).Hepatol Int. 2009 Jun;3(2):323-33. doi: 10.1007/s12072-008-9114-x. Epub 2008 Dec 4. Hepatol Int. 2009. PMID: 19669358 Free PMC article.
Cited by
-
Hepatocellular screening in hepatitis-B infected Asian Americans.J Viral Hepat. 2013 Jul;20(7):515-6. doi: 10.1111/jvh.12070. J Viral Hepat. 2013. PMID: 23730847 Free PMC article. No abstract available.
-
Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.Clin Mol Hepatol. 2016 Sep;22(3):359-365. doi: 10.3350/cmh.2016.0033. Epub 2016 Sep 25. Clin Mol Hepatol. 2016. PMID: 27729630 Free PMC article.
-
Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma.World J Gastrointest Oncol. 2020 Jun 15;12(6):663-676. doi: 10.4251/wjgo.v12.i6.663. World J Gastrointest Oncol. 2020. PMID: 32699581 Free PMC article.
-
Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study.Cancer Manag Res. 2020 Jul 30;12:6597-6606. doi: 10.2147/CMAR.S261368. eCollection 2020. Cancer Manag Res. 2020. PMID: 32848453 Free PMC article.
-
Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy.BMC Cancer. 2024 Oct 8;24(1):1241. doi: 10.1186/s12885-024-13028-5. BMC Cancer. 2024. PMID: 39379833 Free PMC article.
References
-
- Centre for Evidence-Based Medicine. Levels of evidence 2001 [cited 1 Dec 2008]. http://www.cebm.net/index.aspx?o=1025
-
- Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, vol. VIII. Lyon: IARC Scientific; 2002. Publication No.: 155
-
- Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet. 1981;2:1129–1133. - PubMed
-
- Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328:1797–1801. - PubMed
-
- Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology. 1991;13:398–406. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical